Two Recent Federal Circuit Patent Cases

Objective Indicia of Nonobviousness and Restrictive Scope of Patent Reissue Please join us on Monday, September 11, 2023, where we will discuss two recent precedential opinions from the U.S. Court of Appeals for the Federal Circuit in the patent sphere addressing [1] when evidence of objective indicia of nonobviousness is correctly argued and [2] issues [...]

By |2023-11-09T13:30:10-08:00September 8th, 2023|Reissue, Obviousness, Guest Speaker, Patent|0 Comments

Shifting Arguments in Inter Partes Review

SoCal IP Law Institute MCLE meeting of August 21, 2023 - Shifting Arguments in Inter Partes Review Please join us Monday, August 21, 2023 where we will discuss two recent ruling regarding when a petitioner may raise new arguments during inter partes review.  Specific case discussions will include: Axonics, Inc. v. Medtronic, Inc., 2022-1532 (Fed. [...]

By |2023-11-09T13:30:17-08:00August 20th, 2023|Litigation, Patent, Inter Partes Review|0 Comments

Remedies for Patent, Trademark, and Copyright Infringementi

Remedies for Patent, Trademark, and Copyright Infringement Patent The remedy statute for patent infringement states, “Upon finding for the claimant the court shall award the claimant damages adequate to compensate for the infringement, but in no event less than a reasonable royalty for the use made of the invention by the infringer, together with interest [...]

By |2023-03-15T09:42:11-07:00March 14th, 2023|Copyright, Patent, Trademark, Counterfeit, Damages|0 Comments

CAFC regarding written description and section 101

Please join us on Monday, March 13, 2023 at Noon , where we will discuss two CAFC decision for Patents: one re: Written Description requirements and the other re: Patentable Subject Matter under Section 101. For CAFC Written Description requirements, please see: University of Minnesota v. Gilead Sciences at 21-2168.OPINION.3-6-2023_2090143. For CAFC re: Patentable Subject [...]

Rx patent monopoly and Lizzo TM win

Please join us Monday, March 6, 2023 where we will discuss Rx patent monopoly issues and Lizzo's TM win.  Specific case discussions will include: AbbVie Rx Patent Monopoly Strategy Against Biosimilars - AbbVie makes Humera for arthritis and extended its monopoly for 7 years past the 2016 expiration date of its basic patent on the [...]

By |2023-11-09T13:31:44-08:00March 2nd, 2023|Antitrust, FDA, Patent, Trademark, TTAB, monopoly|0 Comments

Emerging IP issues in Artificial Intelligence

SoCal IP Law Institute MCLE meeting of February 27, 2023 - Emerging IP issues in Artificial Intelligence Please join us Monday, February 27, 2023 where we will discuss emerging IP issues related to artificial intelligence.  Specific case discussions will include: Zarya of the Dawn copyright registration cancellation Thaler v. Vidal (AI inventor case) Andersen et [...]

By |2023-11-09T13:31:51-08:00February 26th, 2023|Copyright, Infringement, Patent, Authorship|0 Comments

Grecia is the Word, Have You Heard, His Complaints were Dismissed?

Judges won't readily dismiss a lawsuit. Usually, they will give the plaintiff several chances to correct flaws in a complaint before dismissing with prejudice. It's especially rare to see a judge dismiss a patent suit with prejudice because the infringement allegation is so weak that the patentee has no chance of success. These rare cases [...]

By |2023-02-12T20:08:17-08:00February 12th, 2023|Litigation, Patent, Pleading Standards|0 Comments

Patent Venue

SoCal IP Law Institute MCLE meeting of December 12, 2022 - Two New Patent Venue Cases Please join us on Monday, December 12, 2022, at 12:00 p.m. where we will discuss a pair of venue decisions bearing on patent practice: In re Monolithic Power Sys., 50 F.4th 157 (Fed. Cir. 2022) (here) – Monolithic sought [...]

By |2023-11-09T13:32:00-08:00December 7th, 2022|Patent, Venue|0 Comments

Ninth Circuit Rules in Favor of Yoga Icon Lululemon in a Reverse Trademark Confusion Case over their Align Pants

Vancouver-based Lululemon ("Lulu"), founded in 1998, is famously known for their boujee yoga-inspired activewear. Industry competitor Aliign Activation Wear (“Aliign”) filed suit against Lulu in the Central District of California back in mid-2020, primarily alleging that Lulu was infringing its Aliign trademark, which Aliign said it has been using since 2011. You see, Lulu rolled [...]

Go to Top